Lo Loestrin Fe Kit
Product Images NDC 0430-0420

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lo Loestrin Fe (NDC 0430-0420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Ethinyl Estradiol Is [19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17)-]. (Lo Loestrin Fe 01)

A forest plot chart titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' showing effect estimates from various studies comparing oral contraceptive use versus non-use. The chart includes odds ratios (OR), hazard ratios (HR), and relative risks (RR) with confidence intervals plotted on a horizontal axis ranging from -1.50 to 2.00, visually depicting the risk estimates and their uncertainty for each study.*

FDA Label Image

The Structural Formula For Norethindrone Acetate Is [19-norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17)-]. (Lo Loestrin Fe 02)

Chemical structure diagram of the active ingredient ethinyl estradiol showing its molecular framework with hydroxyl groups and characteristic steroid backbone.*

FDA Label Image

Figure 1. Mean (± Sd) Plasma Ethinyl Estradiol Concentration Versus Time Profiles Following Single- And Multiple-dose Oral Administration Of Lo Loestrin Fe To Healthy Female Volunteers (n = 15) (Lo Loestrin Fe 03)

Chemical structure diagram of norethindrone acetate, one of the active ingredients in Lo Loestrin Fe. The structure shows the molecular components and arrangement typical of a steroidal compound.*

FDA Label Image

Figure 2. Mean (± Sd) Plasma Norethindrone Concentration Versus Time Profiles Following Single- And Multiple-dose Oral Administration Of Lo Loestrin Fe To Healthy Female Volunteers (n = 15) (Lo Loestrin Fe 04)

A line graph showing mean concentration (pg/mL) over time (hours) for three different time points: Day 1, Day 24, and Day 26. The graph depicts the decline of mean concentration in the time range from 0 to 60 hours, with error bars indicating variability at each time point.*

FDA Label Image

The Following Chart Shows The Chance Of Getting Pregnant For Women Who Use Different Methods Of Birth Control. Each Box On The Chart Contains A List Of Birth Control Methods That Are Similar In Effectiveness. The Most Effective Methods Are At The Top Of The Chart. The Box On The Bottom Of The Chart Shows The Chance Of Getting Pregnant For Women Who Do Not Use Birth Control And Are Trying To Get Pregnant. (Lo Loestrin Fe 05)

A line graph showing mean concentration (pg/mL) over 24 hours (Time h) measured on Day 1 and Day 24. The graph plots two lines with error bars: a dashed line for Day 24 and a dotted line for Day 1, illustrating how concentration changes over time after dosing.*

FDA Label Image

2. Look At Your Pill Pack: The Lo Loestrin Fe Pill Pack Has 24 "active" Blue Pills (with Hormones) And 2 “active” White Pills (with Hormones) For Weeks 1, 2, 3 And Part Of Week 4. The Pill Pack Also Has 2 "reminder" Brown Pills (without Hormones) For The Last Part Of Week 4. (Lo Loestrin Fe 06)

An illustration depicting pregnancy rates per 100 women in one year, from fewer than 1 to 85 or more pregnancies, arranged vertically with an arrow indicating fewer pregnancies at the top and more pregnancies at the bottom. It categorizes birth control methods: implants, injections, intrauterine devices, and sterilization at the top; birth control pills, skin patch, and vaginal ring with hormones next; condoms and diaphragm below that; no sex during fertile days, spermicide, and withdrawal further down; and no birth control at the bottom.*

FDA Label Image

Principal Display Panelndc 0430-0420-14lo Loestrin Fe26 Days Of Active Therapy5 Blister Cards Of 28 Tablets Eachrx Only (Lo Loestrin Fe 07)

Lo Loestrin Fe kit blister packaging label displaying a 28-day pill pack with 4 rows labeled Week 1 through Week 4. Each row contains 7 circular pill compartments marked with days of the week (Sun through Sat). Instructions indicate starting on the day label strip matching the first day of the period and taking pills from left to right each week. The label includes Allergan branding and product identification.*

FDA Label Image

Principal Display Panelndc 0430-0420-95lo Loestrin Fe26 Days Of Active Therapy1 Blister Card Of 28 Tablets Eachrx Only (Lo Loestrin Fe 08)

Packaging label for Lo Loestrin Fe kit by Allergan, Inc. The kit includes norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate tablets, with strengths of 1 mg/10 mcg and 10 mg respectively. The label states it provides 26 days of active therapy with 5 blister cards of 28 tablets each and includes storage instructions and barcode.*

FDA Label Image

Lo Loestrin Fe 09

Lo Loestrin Fe kit packaging label featuring norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate tablets at strengths of 1 mg, 10 mcg, and 10 mg respectively. The label indicates 26 days of active therapy, is marked as physician's sample not for sale, and is manufactured by Allergan, Inc. The package contains one blister card of 28 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.